On February 2, 2026, BitMine Immersion (BMNR) fell 11.53% premarket to $22.21 at 6:21 AM EST. The drop follows mounting unrealized losses exceeding $6 billion on its more than 4.24 million ETH position, according to Dropstab, after a 40,302 ETH purchase last week. BMNR previously closed at $25.10 on January 30.

On January 30, 2026, GameStop rose 3.73% to $23.64 as CEO Ryan Cohen detailed plans to pursue a large acquisition. Michael Burry said he added shares and backed deploying as much as $10 billion, while the company's cash of about $9 billion and revised incentives tie potential awards to a $100 billion valuation.

On January 27, 2026, Richtech Robotics Inc. shares rose 10.89% after the company revealed a strategic collaboration with Microsoft’s AI Co-Innovation Labs. The partnership will integrate Azure AI-powered agentic intelligence into Richtech’s ADAM robot and broader automation portfolio, while the stock traded around $4.2250 on heavy volume. The move comes amid strong recent performance for RR, including double-digit year-to-date and one-year returns and analyst targets as high as $6.00.

United Parcel Service reported non-GAAP adjusted diluted EPS of $2.38 and consolidated revenue of $24.5 billion for Q4 2025, both above market expectations. The company outlined 2026 guidance with projected consolidated revenue of about $89.7 billion, planned capital expenditures near $3.0 billion and expected dividend payments of roughly $5.4 billion, alongside an anticipated effective tax rate of approximately 23.0%.

On Tuesday, January 27, 2026, Humana's stock dropped 13.49% in premarket trading to $228.00 after U.S. officials proposed a nearly flat 0.09% net average payment increase for Medicare Advantage plans in 2027. The move, far below prior expectations for a higher hike, pressured Humana and other major health insurers as investors reassessed profit outlooks tied to the Medicare Advantage business.

On January 23, 2026, Novo Nordisk shares advanced after the new oral Wegovy weight-loss pill logged 18,410 first-week prescriptions and outpaced Eli Lilly's Zepbound. The rally was reinforced by a Buy rating from Goldman Sachs, as investors focused on the drugmaker's earnings outlook and expanding position in the GLP-1 obesity market.

Rocket Lab’s RKLB stock slid 5.39% to $83.08 on January 22, 2026, after the company reported a rupture in the Neutron rocket’s Stage 1 tank during qualification testing a day earlier. The incident has sparked concern about possible delays to the Neutron launch schedule, even as Rocket Lab completed a successful Electron mission deploying two satellites for Open Cosmos.

Procter & Gamble reported fiscal Q2 2026 net sales of $22.2 billion and core EPS of $1.88, with earnings slightly ahead of market estimates but revenue below consensus. The company kept its full‑year 2026 guidance for sales and core EPS growth, while trimming its outlook for diluted EPS growth due to higher restructuring charges. It also projected neutral commodity costs, a positive after‑tax currency benefit of about $200 million, and roughly $400 million in tariff‑related after‑tax costs for the fiscal year.

On January 22, 2026, GameStop Corp. shares advanced in premarket trading after Chairman and CEO Ryan Cohen disclosed a second straight day of large open-market purchases totaling 500,000 shares. The new buying lifted his stake to about 42.08 million shares, or roughly 9.3% of the company, and coincided with GME trading around $22.39 before the opening bell.